On July 5, the U.S. Geological Survey released findings that suggest at least 45% of the nation’s tap water could be contaminated with PFAS, commonly known as “forever chemicals.” Now, as many Americans express their concern, one environmental health expert…
Tag: CARCINOGENS
CBD shows promise for reducing cigarette smoking
Cannabidiol or CBD, a non-psychoactive component of cannabis, inhibits the metabolism of nicotine, new research has found, meaning it could help tobacco users curb the urge for that next cigarette.
Study finds most U.S. children use potentially toxic makeup products, often during play
A study by scientists at Columbia University Mailman School of Public Health and Earthjustice found that most children in the United States use makeup and body products that may contain carcinogens and other toxic chemicals.
Frequent Consumption of Peanuts by Cancer Patients May Increase Risk of Cancer Spread
A study by University of Liverpool researchers has identified new factors accompanying previous findings that frequent consumption of peanuts by cancer patients could increase risk of cancer spread.
Oncotarget: Replication-stress sensitivity in breast cancer cells
Taken together these Oncotarget findings show that the CTD and OD domains of mtp53 R273H play critical roles in mutant p53 GOF that pertain to processes associated with DNA replication.
Oncotarget: TERT and its binding protein: overexpression of GABPA/B in gliomas
This Oncotarget study confirms the upregulation of TERT in primary glioblastomas while all GABP proteins rise with the malignancy of the gliomas
Oncotarget: Fgr and Numb in retinoic differentiation and G0 arrest of non-APL AML cells
In sum the Oncotarget data support a paradigm where signaling molecules bound to a Numb scaffold in a signalsome are activated by RA-induced Fgr expression
Hundreds of chemicals, many in consumer products, could increase breast cancer risk
List includes potential carcinogens that act by stimulating production of hormones that fuel breast tumors
Oncotarget: Subtypes of thymic epithelial tumors independent of WHO type
These Oncotarget results may reflect the unselected patient population enrolled in these studies, including no selection for WHO histologic subtype or molecular aberrations.
Oncotarget: Biomechanics in response to drug in hypoxia by atomic force spectroscopy
These Oncotarget results show that a degree of chemotherapeutic drug effects on biomechanical and biophysical properties of cancer cells is distinguishable in normoxia and hypoxia`
Oncotarget: Cutaneous apocrine sweat gland carcinoma
Together these Oncotarget results describe the first ever CAC case with a BRCAness genetic background
Oncotarget: Caspase-11 and AIM2 inflammasome involved in COPD and lung adenocarcinoma
The Oncotarget authors found that AIM2 inflammasome is at the crossroad between COPD and lung cancer in that its higher presence is correlated to lower survival rate of smoking COPD adenocarcinoma patients.
Oncotarget: RAS reversion in colorectal cancer patients treated with bevacizumab
This Oncotarget finding might have potential therapeutic implications, as anti-EGFR could be reconsidered in primarily RAS mutant patients reverted to a wild-type status after bevacizumab exposure.
Oncotarget: CEA as a blood-based biomarker in anal cancer
CEA is not associated with survival outcomes in SCCA, and is not a clinically relevant biomarker in this disease
Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia
These Oncotarget findings demonstrate that Tomivosertib exhibits potent anti-leukemic properties on AML cells and support the development of clinical translational efforts involving the use of this drug
Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network
EGCG, a green tea polyphenol, as a modulator of in vitro methylglyoxal-induced Tau glycation and its impact on reducing advanced glycation end products in neuroblastoma cells.
Oncotarget: LAPAS1 is required for S phase progression and cell proliferation
They identify LAPAS1 as a novel E2F-regulated lncRNA that has a potential role in human cancer and regulates cell-cycle progression and cell proliferation
Oncotarget: Urine RNA reveal tumor markers for human bladder cancer
This Oncotarget work strongly suggests exploiting urine RNAs as diagnostic markers of bladder cancer and it suggests specific novel markers.
Oncotarget: miRNA signatures from epidermal growth factor inhibitor patients
This Oncotarget study suggests that miR-21, miR-31 and miR-520e expression might be a treatment dependent marker for EGFRI induced skin rash.
Banishing cigarettes into history’s ashcan
New grant expands Texas tobacco program, targets substance use patients in rural communities
Oncotarget: Epithelial-mesenchymal transitions create endothelial cells and tumor growth
Cells that have undergone EMT can promote tumor growth and neovascularization either indirectly, by promoting endothelial transdifferentiation of carcinoma cells, or directly, by acquiring an endothelial phenotype, with FOXC2 playing key roles in these pr
Oncotarget: General anesthesia for pancreatic cancer surgery
The major finding of this Oncotarget study was perioperative tryptophan depletion and increased taurine synthesis.
Oncotarget: Genome wide DNA methylation landscape reveals glioblastoma’s influence
These Oncotarget results suggest that GBM might induce epigenetic alterations in tumor infiltrating CD4 T-cells
Oncotarget: Loss of CPAP in oral cancer
CPAP also plays a vital role in suppressing tumorigenesis in OSCC by facilitating EGFR homeostasis
Reactive oxygen species (ROS): Key components in cancer therapies
The article by Dr. Biswa Mohan Sahoo et al. is published in Anti-Cancer Agents in Medicinal Chemistry, 2021
Running in the blood: Blood lipids are linked to cancer, but depending on family history
Medical researchers identify the role of family history in the link between blood lipids and esophageal cancer
Red meat consumption may promote DNA damage-assoc. mutation in colorectral cancer patients
Study provides mechanistic link between red meat consumption and colorectal cancer development
Five Pew-Stewart scholars chosen to advance cutting-edge cancer research
PHILADELPHIA–The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2021 class of the Pew-Stewart Scholars Program for Cancer Research. The five early-career scholars who comprise the 2021 class will each receive a four-year grant to…
Oncotarget: The drug sensitivity of hepatocellular cancer cells
‘Hepatocellular carcinoma (HCC) is the third leading cause of cancer related death worldwide, with a poor median survival time after diagnosis of six months’
Coloring tumors reveals their bad influence
Studies on cancer are limited by the threshold at which cellular transformations become clinically detectable. However, the very initial phase on the way to malignancy is histologically invisible, as the process originates from one single cell. In this early phase,…
Oncotarget: E6-specific inhibitors as therapeutics for HPV+ head and neck carcinomas
‘Head and neck squamous cell carcinomas (HNSCC) are heterogeneous tumors that arise in the upper respiratory tract and are the 6th most common cancer worldwide by incidence’
Oncotarget: Lung squamous cell carcinoma tumors reveal therapeutic alterations
Lung cancer is the leading cause of cancer-related deaths across the globe with more than 1.7 million deaths annually’
Lead levels in urban soil are declining but hotspots persist
Decades after federal bans ended widespread use of lead-based paint and gasoline, some urban soils still contain lead levels that exceed children’s safety guidelines
Impact Journals to present on scientific integrity at SSP Annual Meeting
Impact Journals is an exhibitor/sponsor and will be presenting our scientific integrity process at the Society for Scholarly Publishing (SSP) Annual Meeting, occurring virtually from May 24-27, 2021
‘No level of smoke exposure is safe’
Study links secondhand smoke during pregnancy to epigenetic changes in babies
Study shows racial differences in personal care product use, may lead to health inequities
Findings could explain why women of color in particular are more highly exposed to harmful chemicals
Frontiers in Clinical Drug Research – Anti-Cancer Agents
Bentham Science has recently launched the new volume of the book, Frontiers in Clinical Drug Research – Anti-Cancer Agents. Frontiers in Clinical Drug Research – Anti-Cancer Agents is a book series essential for pharmaceutical scientists, postgraduate students and researchers seeking…
Inflammation and inflammatory markers of head and neck tumor
‘Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem’ aims to highlight the significant roles of inflammation in head and neck malignancy. This entails the screening, diagnosis, treatment as well as follow-up schemes of head and neck cancer patients. Now,…
Risk prediction to reduce minority disparities in USPSTF lung cancer screening guidelines
Updated USPSTF LCS guidelines based solely on age, pack-years, and quit-years perpetuate eligibility disparities among racial and ethnic minorities, although incorporating certain risk prediction models may help reduce such inequalities
Oncotarget: Phase 1 study of Z-Endoxifen in patients with solid tumors
The Oncotarget article provides evidence that antitumor activity and prolonged stable disease are achieved with Z-endoxifen despite prior tamoxifen therapy.
Want a healthier home? Start with your couch
Replacing an old couch with a new one free of flame retardants reduces harmful exposures in the home
Association found between consumption of ultra-processed foods and drinks and colorectal cancer risk
Consumption of ultra-processed foods and drink could increase the risk of developing colorectal cancer. This was the conclusion of a large study undertaken by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, based…
Drug used during pregnancy may increase cancer risk in mother’s adult children
Hydroxyprogesterone caproate may contribute to increasing rates of early-onset cancer, researchers say
New Barrett’s esophagus monitoring method could aid in easier and more precise prognoses
CLEVELAND–A new technique for sampling and testing cells from Barrett’s esophagus (BE) patients could result in earlier and easier identification of patients whose disease has progressed toward cancer or whose disease is at high risk of progressing toward cancer, according…
Oncotarget: Hispanic Chronic myelomonocytic leukemia patients
This Oncotarget study had significantly lower mutation rates in ASXL1 and SETBP1, and a higher rate of muTET2/wtASXL1
Oncotarget: Ibuprofen disrupts protein complex in colorectal cells
The Oncotarget data shed new light on the biochemical mechanisms behind ibuprofen’s action on alternative spliced RAC1B and may support its use in personalized approaches to CRC therapy or chemoprevention regimens.
Oncotarget: Predictors of immunotherapy benefit in Merkel cell carcinoma
Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, “Merkel cell carcinoma (MCC) is a relatively rare cancer, with roughly 400 cases per 100,000 persons each year in the United States”
Oncotarget: Quantitative proteome profiling stratifies fibroepithelial lesions of the breast
The present Oncotarget work shed light on a brief mechanistic framework of PTs aggressive nature and present potential biomarkers to differentiate overlapping FELs that would be of practical utility in augmenting existing diagnosis and disease management
Oncotarget: Genomic and neoantigen evolution in head and neck squamous cell carcinoma
In this Oncotarget study, the authors characterized the mutational and neoantigen burden between primary and first recurrence tumors in 23 patients with HNSCC
Exposure to common chemical during pregnancy may reduce protection against breast cancer
UMass Amherst research suggests propylparaben is an endocrine disruptor